Post Doc. Researcher – Başak Özata

basak

ozata@sabanciuniv.edu

+90 (216) 483 90 00

Biosimilar drug, drug design and analysis, masss pectrometry, intactmAb, peptide mapping and glycan analysis.

1. – Otofaji ve Kanser (Autophagy and Cancer). Gözüaçık D*, Karakaş HE, Akkoç Y, Özata B. Chapter in the book:Kanser Moleküler Biyolojisi (Cancer Molecular Biology), 2018. Yusuf Baran (Ed.)
2. – Synthesis and Biological Properties of Novel Brefeldin A Analogues. Kai Seehafer, Frank Rominger, Günter Helmchen, Markus Langhans, David G. Robinson, BaşakÖzata, Britta Brügger, Jeroen R. P. M. Strating, Frank J. M. van Kuppeveld, and Christian D. Klein. J. Med. Chem., 2013, 56 (14), 5872–5884.
3. – Molecular recognition of a single sphingolipid species by a protein’s transmembrane domain. F.-Xabier Contreras, Andreas M. Ernst, Per Haberkant, PatrikBjörkholm, Erik Lindahl, Başak Gönen, Christian Tischer, Arne Elofsson, Gunnar von Heijne, Christoph Thiele, Rainer Pepperkok, Felix Wieland & Britta Brügger. Nature, 2012, 481, 525-529.
4. – Syntheses and Biological Properties of Brefeldin Analogues. Sebastian Förster, ElkePersch, OlenaTverskoy, Frank Rominger, Günter Helmchen, Christian Klein, BasakGönen, and Britta Brügger. Eur. J. Org. Chem., 2011, 878–891.
5. – Synapsin Utilization Differs Among Functional Classes of Synapses on Thalamicortical Cells. A.Kielland, A.Erisir, I. Walaas, P. Heggelund. Journal of Neuroscience, 2006, 26(21):5786-93. (Acknowledged for my contributions to data collection)

Türk İmmünoloji Derneği
Moleküler Bioyoloji Derneği